Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 2Whooping Cough 1Pneumococcal Infections 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Measles 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Hepatitis B 1HIV Infections 1

Interventions

Whole-Body Irradiation 6Peripheral Blood Stem Cell Transplantation 6fludarabine phosphate 5Etoposide 5Cyclosporine 4Mycophenolic Acid 3Methotrexate 3Melphalan 3Cyclophosphamide 3Antilymphocyte Serum 3pegaspargase 2Methylprednisolone 2Cytarabine 2Carmustine 2Busulfan 2thymoglobulin 1plerixafor 1denileukin diftitox 1Vincristine 1Thiotepa 1Salvia hispanica seed extract 1Radiotherapy 1Psychiatric Rehabilitation 1Prednisone 1Positron-Emission Tomography 1Oxycodone 1Ondansetron 1O(6)-benzylguanine 1Morphine 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Extranodal NK-T-Cell × Heptavalent Pneumococcal Conjugate Vaccine × Clear all
NCT00569309 2018-03-12

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
30 enrolled 8 charts
LymphoidPlasma cell

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡